ACCD Stock Overview
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
Accolade, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.61 |
| 52 Week High | US$22.92 |
| 52 Week Low | US$4.61 |
| Beta | 1.36 |
| 1 Month Change | 44.35% |
| 3 Month Change | -3.63% |
| 1 Year Change | -39.54% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -64.28% |
Recent News & Updates
Shareholder Returns
| ACCD | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 15.7% | 1.0% | 3.1% |
| 1Y | -39.5% | 1.8% | -8.5% |
Return vs Industry: ACCD underperformed the US Healthcare industry which returned 1.8% over the past year.
Return vs Market: ACCD underperformed the US Market which returned -8.5% over the past year.
Price Volatility
| ACCD volatility | |
|---|---|
| ACCD Average Weekly Movement | 13.1% |
| Healthcare Industry Average Movement | 7.7% |
| Market Average Movement | 7.0% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: ACCD is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week.
Volatility Over Time: ACCD's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 2,350 | Raj Singh | https://www.accolade.com |
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services.
Accolade, Inc. Fundamentals Summary
| ACCD fundamental statistics | |
|---|---|
| Market Cap | US$772.27m |
| Earnings (TTM) | -US$463.77m |
| Revenue (TTM) | US$357.87m |
2.2x
P/S Ratio-1.7x
P/E RatioIs ACCD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ACCD income statement (TTM) | |
|---|---|
| Revenue | US$357.87m |
| Cost of Revenue | US$191.45m |
| Gross Profit | US$166.42m |
| Other Expenses | US$630.20m |
| Earnings | -US$463.77m |
Last Reported Earnings
Nov 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -6.37 |
| Gross Margin | 46.50% |
| Net Profit Margin | -129.59% |
| Debt/Equity Ratio | 58.0% |
How did ACCD perform over the long term?
See historical performance and comparison